First Page | Document Content | |
---|---|---|
Health Pharmaceuticals policy Clinical research Federal Department of Home Affairs Swissmedic Pharmaceutical industry Healthcare quality Marketing authorization Statistical process control Pharmacovigilance IB Bioequivalence | ZL300_00_001e_WL Guidance document Variations and extensions HMV4Add to Reading ListSource URL: www.swissmedic.chDownload Document from Source WebsiteFile Size: 434,97 KBShare Document on Facebook |